FIELD: chemistry.
SUBSTANCE: invention relates to a crystalline form of allisartan isoproxil which has diffraction peaks at diffraction angles (2θ±0.2°) 6.9, 8.0, 13.8, 20.1, 21.1, 22.2, 24.0 and 27.7 in spectra of pRSA. Invention also relates to a pharmaceutical composition of allisartan isoproxil for the treatment of hypertensive diseases.
EFFECT: produced is a novel crystalline form of allisartan isoproxil, having good mobility and high stability.
11 cl, 7 dwg, 8 ex
| Title |
Year |
Author |
Number |
| AMORPHOUS ALLISARTAN ISOPROXIL, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION CONTAINING AMORPHOUS ALLISARTAN ISOPROXIL |
2014 |
- Tan Duanming
- Ou Jun
- Ye Guanhao
- Bu Shui
|
RU2668267C2 |
| NEW CRYSTALS OF URACIL COMPOUND |
2016 |
|
RU2686722C1 |
| STABLE CRYSTALLINE FORM OF TYPIRACYL HYDROCHLORIDE AND METHOD FOR ITS CRYSTALLIZATION |
2014 |
- Kadzuno Khideki
- Mutsumi Tomonobu
|
RU2640417C2 |
| AZABICYCLIC COMPOUND CRYSTALS |
2016 |
|
RU2697521C2 |
| STABLE CRYSTALLINE FORM OF TIPIRACIL HYDROCHLORIDE AND METHOD FOR ITS CRYSTALLIZATION |
2014 |
- Kadzuno Khideki
- Mutsumi Tomonobu
|
RU2674441C1 |
| CRYSTALLINE FORM OF SODIUM ERTAPENEM AND PREPARATION METHOD THEREOF |
2011 |
- Shi In
- Li Kun
- Chzhao Sjuebin
- Se Tszan
- Ma Jujsju
- Lv Tszjan
- Tszja Min
|
RU2583052C2 |
| CRYSTALLINE SALT OF NINTEDANIB DIETHANESULFONATE AND METHOD FOR PRODUCTION AND USE THEREOF |
2016 |
- Wang Hubo
- Zhu Xueyan
- Guo Meng
- Hu Mingtong
- Zhang Jiasong
- Sun Jiude
|
RU2708683C2 |
| LONG-ACTING DPP-IV INHIBITOR CRYSTAL AND ITS SALTS |
2017 |
- Sang Guangming
- Liu Lin
- Zhang Aiming
- Qiao Jiabin
- Guo Xiaopeng
- Zhang Xiquan
- Xia Chunguang
|
RU2753335C2 |
| SYK INHIBITOR SALT AND CRYSTALLINE FORM THEREOF |
2019 |
- Tsyan, Venyuan
- Van, Khuntszyan
- Chzhan, Min
- Lyu, Fej
- Sin, Lej
- Khu, Chzhunyuan
- Go, Yakhuej
- Lyu, Yanlun
- Chzhan, Khuejkhuej
|
RU2818103C2 |
| AMINE SOLVATE OF SODIUM GLUCOSE OPENER OF SODIUM GLUCOSE OPENER AND METHOD FOR PRODUCTION THEREOF AND USE THEREOF |
2017 |
|
RU2710230C1 |
